FDA Investigator Deborah J Parris

Deborah J Parris has conducted inspections on 24 sites in 2 countries as of 20 Jan 2016. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
24
Last Inspection Date:
20 Jan 2016
Investigator Role:
FDA Investigator
Redica ID:
100002002
Countries of Inspections:
United States of America, China
FDA Investigators that have inspected at least one site in common with Deborah J Parris:
Adree N Anderson, Alice S Tsao, Alison N Correll, Alison N Stieg, Allison A Aldridge, PhD, Ana Paulap Sandee, Anastasia I Offordile, Andrew Byro, Anita R Michael, Ankur C Patel, Anthony J Donato, Audrey Thereset Uy, Brandon L Mariner, Brooke K Higgins, Bruce C Kovak, Burnell M Henry, Carol A Robles, Cary Greene, Charisse K Green, Christina K Theodorou, Christopher S Fields, Clarice J Ahn, Craig D Zagata, Cynthia A Palmer, Cynthia Jim, CSO, Daniel J Deciero, Daniel J Min, Daryl A Dewoskin, David A Oluwo, David J Hafner, Debra J Bennett, Debra L Pagano, Devon Jenkins, Diane T Bargo, Donald L Lech, Dr. Robert C Horan, MD, Edmund F Mrak, Jr, Edward D Mcdonald, Edward E Lockwood (EEL), Elaine E Gilfillan, Emest F Bizjak, Eric L Dong, BS, Eric M Padgett, Erika V Butler, Felix Maldonado, Gayle S Lawson, Gillian B Nardelli, Guerlain Ulysse, Hala L Selby, Hala Lj Whetstone, Helen B Ricalde, Jacqueline Mdiaz Albertini, Jaison J Eapen, James A Liubicich, James I Giefer, James M Mason, Jeen S Min, Jill M Sooter, Jill Mielziner, Jo Annc Declement, Joey C West, John P Mistler, Jose Ohernandez Guzman, Jose R Hernandez, Joy P Matthias, Judith A Jones, Junho Pak, Karen C Daugherty, Karen E D'orazio, Karishma G Gopaul, Keith M Reilly, Kendra L Brooks, Kevin A Gonzalez, Kristen D Evans, Kristina J Donohue, Larry K Austin, LCDR Debra Emerson, LCDR Margaret Edi Gennaro, Loretta Nemchik, LT John M Mastalski, Luis A Dasta, Luis Mburgos Medero, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marcus A Ray, Margaret Faulkner, Maria A Reed, Matthew J Johnson, Matthew R Noonan, Megan A Haggerty, Melissa J Garcia, Meredith L Sheridan, Meredith P Soehl, Investigator, Michael A Charles, Michael A Taylor, Michael D Omeara, Michael J Nerz, Michael L Casner, Michael Rosner, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Mihaly S Ligmond, Nancy T Waites, Nebil A Oumer, Nicole K Trudel, Niketa Patel, Parul M Patel, Patricia F Hughes, PhD, Paula A Trost, Qin Xu, Qing Joanna Zhou, PhD, Rachael O Oyewole, Rachel C Harrington, Raffi B Papazian, Ramanda C Gregory, Raymond L Cheung, Remache, Reyes Candau Chacon, PhD, Robert C Steyert, Robert J Ham, Robert J Maffei, Robin P Mathew, Rory K Geyer, Roseline N Boateng, Russell J Glapion, Sam Pepe, Sarah E Rhoades, Schultz, Sean R Marcsisin, Shantelle I Hughes, Shirley J Berryman, Sony Mathews, Stacey S Degarmo, Stephanie Mangigian, MS/OSH, RN, Steven D Kehoe, Susan F Laska, MS, Suzanne M Healy, Tammy L Chavis, Tara L Greene, Tekalign Wondimu, Terry Bridgewater, Thomas E Friel, Thomas J Mooney, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiffani D Wilson, Torrey M Ward, Valerie L Whipp, Vlada Matusovsky, Walsworth, Wayne D Mcgrath, William J Leonard, William J Muszynski, Yvonne C Mcknight

Deborah J Parris's Documents

Publish Date Document Type Title
June, 2015 FDA 483 AbbVie Bioresearch Center - Form 483, 2015-06-11
June, 2015 EIR Gemini Pharmaceuticals, Inc. dba Plus Pharma - EIR, 2015-06-30
October, 2015 FDA 483 EMS ACQUISITION CORP. - Form 483, 2015-10-22
January, 2015 FDA 483 Response Abbey Color Incorporated - Form 483R, 2015-02-10
June, 2015 FDA 483 Gemini Pharmaceuticals, Inc. dba Plus Pharma - Form 483, 2015-06-30
March, 2015 EIR BioSpectra, Inc. - EIR, 2015-03-05
March, 2015 FDA 483 BioSpectra, Inc. - Form 483, 2015-03-05
April, 2015 FDA 483 Polysciences, Inc. - Form 483, 2015-04-29
July, 2015 EIR Medical Products Laboratories, Inc. - EIR, 2015-07-21
January, 2016 EIR West Services and Solutions LLC - EIR, 2016-01-22
August, 2015 EIR Sharp Clinical Services, LLC - EIR, 2015-08-27
July, 2015 FDA 483 Medical Products Laboratories, Inc. - Form 483, 2015-07-21
November, 2014 FDA 483 Sigmapharm Laboratories, LLC - Form 483, 2014-11-19
November, 2015 FDA 483 Central Admixture Pharmacy Services, Inc. - Form 483, 2015-11-20
August, 2015 FDA 483 Jubilant Cadista Pharmaceuticals, Inc. - Form 483, 2015-08-07
June, 2014 EIR SpecGx LLC - EIR, 2014-06-12
June, 2015 EIR AbbVie Bioresearch Center - EIR, 2015-06-11
January, 2015 FDA 483 Abbey Color Incorporated - Form 483, 2015-01-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more